A former Connecticut insurance agent allegedly defrauded nine victims across multiple states through fake policies, forged documents, and impersonated professionals.
A new study on golden retrievers reveals how wildfire smoke impacts pet and human health, with implications for insurance costs, coverage, and long-term risk management.
Florida officials are warning consumers after more than 20 people, including children, fell ill from drinking raw milk linked to a single farm in the state.
Dog-walking injuries are on the rise, especially among women aged 40-64. From leash burns to falls, here’s how to protect yourself and why your insurance may not help.
As private equity firms rapidly reshape life insurance with asset-focused strategies, incumbents face pressure to adapt or risk being outpaced in a changing market.
A new WCRI report explores how fee schedule policies and inflation trends from 2021 to 2025 have led to varying medical cost growth in state workers’ compensation systems.
Seniors are increasingly targeted by fake insurance offers over the phone. Learn how to spot the red flags, protect yourself, and report health insurance scams.
Millions of Americans are paying more than ever for health, auto, home, and life insurance—stretching their budgets thin and fueling a growing crisis of insurance poverty.
James and Maureen Wilson of Owings Mills, Maryland, received prison time and must repay over $18.7 million after orchestrating a massive life insurance fraud scheme.
Rhode Island’s new Pet Insurance Act introduces detailed consumer protections, requiring clear disclosures and training for producers starting January 1, 2026.
Artificial intelligence and outcome-focused care models are streamlining workers’ compensation by improving triage, reducing costs, and prioritizing long-term recovery outcomes.
Fifty-five states and territories back Purdue Pharma’s $7.4B opioid settlement plan, aiming to resolve lawsuits and distribute funds to governments, tribes, and individuals.
Twenty-seven states and D.C. filed suit to block the sale of genetic and medical data in 23andMe’s bankruptcy, citing lack of informed customer consent.